NCT01686165 2018-08-28Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHLUniversity of ArizonaPhase 2 Completed5 enrolled 8 charts
NCT00073957 2018-01-23Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's LymphomaBeth Israel Deaconess Medical CenterPhase 2 Completed25 enrolled 7 charts